GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 60 Degrees Pharmaceuticals Inc (NAS:SXTPW) » Definitions » Pre-Tax Income

60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) Pre-Tax Income : $-0.79 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is 60 Degrees Pharmaceuticals Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. 60 Degrees Pharmaceuticals's pretax income for the three months ended in Mar. 2024 was $0.43 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.79 Mil. 60 Degrees Pharmaceuticals's pretax margin was 368.97%.

During the past 4 years, 60 Degrees Pharmaceuticals's highest Pretax Margin was -139.71%. The lowest was -2769.96%. And the median was -934.37%.


60 Degrees Pharmaceuticals Pre-Tax Income Historical Data

The historical data trend for 60 Degrees Pharmaceuticals's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

60 Degrees Pharmaceuticals Pre-Tax Income Chart

60 Degrees Pharmaceuticals Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
-3.05 -4.26 -6.18 -3.81

60 Degrees Pharmaceuticals Quarterly Data
Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.60 -3.34 4.17 -2.05 0.43

Competitive Comparison of 60 Degrees Pharmaceuticals's Pre-Tax Income

For the Biotechnology subindustry, 60 Degrees Pharmaceuticals's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


60 Degrees Pharmaceuticals's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 60 Degrees Pharmaceuticals's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where 60 Degrees Pharmaceuticals's Pre-Tax Income falls into.



60 Degrees Pharmaceuticals Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

60 Degrees Pharmaceuticals's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-5.155+3.628+-2.287+0+0
=-3.81

60 Degrees Pharmaceuticals's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-1.332+1.761+-0.001+0+5.5511151231258E-17
=0.43

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.79 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


60 Degrees Pharmaceuticals  (NAS:SXTPW) Pre-Tax Income Explanation

60 Degrees Pharmaceuticals's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=0.428/0.116
=368.97%

During the past 4 years, 60 Degrees Pharmaceuticals's highest Pretax Margin was -139.71%. The lowest was -2769.96%. And the median was -934.37%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


60 Degrees Pharmaceuticals Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of 60 Degrees Pharmaceuticals's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
1025 Connecticut Avenue NW, Suite 1000, Washington, D.C, WA, USA, 20036
60 Degrees Pharmaceuticals Inc operates as a specialty pharmaceutical company with the goal of using biological science and applied research to develop and commercialize new therapies for the prevention and treatment of infectious diseases. The firm's pipeline products under development cover development programs for COVID-19, fungal, tick-borne, and other viral diseases through Arakoda and Celgosivir.

60 Degrees Pharmaceuticals (60 Degrees Pharmaceuticals) Headlines